Article Versions Notes

Nishikido S, Akazawa S, Niri T, Inoue S-I, Matsuda K, Aoshi T, Nakashima M, Haraguchi A, Horie I, Kobayashi M, et al. Oral Administration of 5-Aminolevulinic Acid Does Not Ameliorate Autoimmune Diabetes in NOD Mice. Diabetology. 2025; 6(7):62. https://doi.org/10.3390/diabetology6070062

Nishikido, Shinpei, Satoru Akazawa, Tetsuro Niri, Shin-Ichi Inoue, Katsuya Matsuda, Taiki Aoshi, Masahiro Nakashima, Ai Haraguchi, Ichiro Horie, Masakazu Kobayashi, and et al. 2025. "Oral Administration of 5-Aminolevulinic Acid Does Not Ameliorate Autoimmune Diabetes in NOD Mice" Diabetology 6, no. 7: 62. https://doi.org/10.3390/diabetology6070062

Nishikido, S., Akazawa, S., Niri, T., Inoue, S.-I., Matsuda, K., Aoshi, T., Nakashima, M., Haraguchi, A., Horie, I., Kobayashi, M., Okita, M., Kawakami, A., & Abiru, N. (2025). Oral Administration of 5-Aminolevulinic Acid Does Not Ameliorate Autoimmune Diabetes in NOD Mice. Diabetology, 6(7), 62. https://doi.org/10.3390/diabetology6070062